Prof. Jingyu Deng 邓靖宇
Chief Physician, Professor
Department of Gastric Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gastric cancer, including minimally invasive surgery, pylorus- and vagus nerve-preserving surgery for early gastric cancer, and conversion therapy.
Dr. Deng is a Chief Physician, Professor, and PhD supervisor at Tianjin Medical University Cancer Institute & Hospital. Holding a medical doctorate, Dr. Deng is a Tianjin Distinguished Professor. Clinical expertise includes minimally invasive gastric cancer surgery, pylorus- and vagus nerve-preserving procedures for early gastric cancer, and conversion therapy.
Professional roles
- Member, International Gastric Cancer Association
- Standing Committee Member, Gastric Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Laparoscopic Young Physicians Committee, Endoscopic Physicians Branch, Chinese Medical Doctor Association
- Member, Tumor Surgery Physicians Committee, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Deng Jingyu). Papers usually list the name as Jingyu Deng or Deng J.
Selected publications
101 papers on PubMed matched by name and affiliation; 39 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Surg, 2026 (senior author): Development and Validation of a Novel Post-Neoadjuvant Staging System for Gastric Cancer Incorporating Tumor Regression Grade and Lymph Node Status: A Multicenter Retrospective Cohort Study. PubMed 42982333
- Br J Cancer, 2026 (senior author): LAMB3 drives gastric cancer progression through SAMD4A-mediated degradation of PHLPP2 mRNA leading to sustained PI3K-Akt activation. PubMed 42310093
- Int J Gen Med, 2026 (senior author): Restaging pN Classification in Early Gastric Cancer with Inadequate Lymph Node Retrieval: Multi-Institutional Development and Prognostic Validation of a Revised Staging System. PubMed 42153151
- Surg Today, 2025 (senior author): Examining more than 35 lymph nodes improves the staging and survival in resectable advanced gastric cancer: a multi-institutional study in China. PubMed 40353864
- Surgery, 2025 (senior author): Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in China. PubMed 40373505
- Int J Surg, 2025 (senior author): Artificial neural network model enhancing the accuracy of clinical evaluation for high-risk population of lymph node metastasis in non-intestinal type early gastric cancer: a multicenter real-world study in China. PubMed 40265477
- Int J Gen Med, 2025 (senior author): Conditional Survival Rate of Patients Undergoing Gastrectomy with D2 Lymph Node Dissection After Neoadjuvant Chemotherapy: A Retrospective Study. PubMed 40161452
- Dig Liver Dis, 2025 (senior author): The clinical significance assessment of the transverse lymph node metastasis in gastric cancer: The establishment and validation of nomogram from a single clinical medical center. PubMed 39034188
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion